Ginocchio Paul

Average Profitability
41.6%
Insider Buys Quantity
9
Insider Buys Sum
$405,421.36
Insider Sells Quantity
1
Insider Sells Sum
$2,801.26

Insider Activity of Ginocchio Paul

According to the SEC Form 4 filings, Ginocchio Paul, being in a position of

  1. CHIEF FINANCIAL OFFICER at Augmedix, Inc.,
    оver the last 12 months, has bought 10000 shares for $48,500, and sold 2354 shares for $2,801,
    over all time since 2021-05-19, has bought 112000 shares for $405,421, and sold 2354 shares for $2,801.

The largest purchase of all time was on 2021-10-28 and amounted to 34000 shares of Augmedix, Inc. for $136,000.

The largest sale of all time was on 2024-05-15 and amounted to 2354 shares of Augmedix, Inc. for $2,801.

Biography of Ginocchio Paul

No biography is available at this moment.

2024-05-15SaleAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
2,354
0.0048%
$1.19$2,801+89.92%
2023-11-22PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
10,000
0.0244%
$4.85$48,500-30.6%
2022-12-13PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
18,000
0.0485%
$1.20$21,600+241.6%
2022-05-26PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
2,000
0.0057%
$2.04$4,080-13.16%
2021-11-23PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
14,000
0.0385%
$2.96$41,440-27.07%
2021-10-28PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
34,000
0.1008%
$4.00$136,000-34.99%
2021-06-08PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
2,044
0.0076%
$5.50$11,242-37.73%
2021-06-07PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
10,000
0.0309%
$5.00$50,000-42.4%
2021-05-25PurchaseAugmedix, Inc.
AUGX
CHIEF FINANCIAL OFFICER
9,356
0.0322%
$4.56$42,663-28.57%
2021-05-19PurchaseAugmedix, Inc.
AUGX
Chief Financial Officer
12,600
0.0463%
$3.96$49,896-10.28%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.